Cancer Research UK

Cancer Research UK

Cancer Research UK

Overview
Date Founded

2001

Headquarters

Angel Building,407 St. John Street,London, Greater London EC1V 4AD

Industries

Other Business & Consulting Services
Medical Products & Equipment

Company Description

Cancer Research UK provides cancer research services. It supports and undertakes research on the biology and causes of cancer and develops anti-cancer drugs. The firm also provides general information about cancer and types of treatments and funds projects that help patients cope with the side effects of cancer and its treatment. Its institute also operates an online portal CancerHelp UK that provides patient information. The company was founded in 2001 and is headquartered in London, the United Kingdom.

Executives & Employees

Founding Member

Chief Executive Officer

Executive Director of Fundraising & Marketing

Chief Financial Officer & Executive Director-Corporate Resources

Executive Director-Policy & Information

Chief Business Officer

Head of Combination Therapies

Director of Discovery Research & Research Communications

Director-Women of Influence

Chief Scientist

Board of Governors
Paths to Cancer Research UK
Potential Connections via
Relationship Science
You
Cancer Research UK
Advisors & Consultants
Legal Advisor

Partner at DLA Piper

Legal Advisor

Managing Partner at Freshfields Bruckhaus Deringer LLP

Clients

Alnylam Pharmaceuticals, Inc. operates as biopharmaceutical company, which engages in the discovery, development and commercialization of RNAi therapeutics. It is the translation of RNAi as a new class of innovative medicines with a core focus on RNAi therapeutics for the treatment of genetically defined diseases. The company was founded by John Kennedy Clarke, Paul R. Schimmel and Phillip A. Sharp on June 14, 2002 and is headquartered in Cambridge, MA.

Merck KGaA is a science and technology company, which engages in the manufacture of pharmaceutical and chemical products. It operates through the following sectors: Healthcare, Life Science, and Performance Materials. The Healthcare sector discovers, develops, and produces prescription medicines used to treat cancer, multiple sclerosis, and infertility. The Life Science sector provides scientists with laboratory materials, technologies, and services. The Performance Materials sector offers specialty chemicals and materials for demanding applications. The firm offers pharma and biopharma manufacturing, pharmaceutical research, pharma quality control, and government and academic research services. The company was founded by Friedrich Jacob Merck in 1668 and is headquartered in Darmstadt, Germany.

Basilea Pharmaceutica Ltd. is headquartered in Basel, Switzerland, and listed on the SIX Swiss Exchange (SIX:BSLN). Through its fully integrated research and development operations the company focuses on the development of innovative antibiotics, antifungals and oncology drugs, targeting the medical challenge of resistance and non-response to current treatment options.

Non-Profit Donations & Grants Received
Investments
Details Hidden

MISSION Therapeutics Ltd. develops small molecule drugs targeting enzymes involved in cancer and other diseases. It focuses on selectively targeting deubiquitylating enzymes to treat cancer, neurodegenerative and other diseases. The company was founded by Stephen Jackson Philip, Xavier Jacq, Niall M. B. Martin and Keith Menear in 2011 and is headquartered in Cambridge, the United Kingdom.

Details Hidden

PsiOxus Therapeutics Ltd. operates as a biotechnology company which develops novel therapeutics that addresses cancer and other clinically unmet diseases. Its products include Enadenotucirev, Espindolol and AbEnAd. The firm also develops treatments based upon the research phase vaccine platform PolySTAR, which combines recombinant viral vectors with polymers to shield them from the immune system, and the research phase adjuvant and immunotherapeutic platform PolyMAP, which combines polymers with synthetic adjuvants to significantly enhance the effectiveness of vaccines. The company was founded by Andrew Justin Stewart Coats and Stefan D. Anker on November 17, 2006 and is headquartered in Abingdon, the United Kingdom.

Details Hidden

Spear Therapeutics Ltd. develops cancer treatment drugs. The firm offers cytochrome P450 (CYP)-activated prodrugs. It designs prodrugs that are activated by enzymes that are found in cancer tissues. The company was founded by Steven A. Everett and Gerard Andrew Potter and is headquartered in Manchester, the United Kingdom.

Suppliers
Asterias Biotherapeutics, Inc. Pharmaceuticals | Menlo Park, California

Asterias Biotherapeutics, Inc. is a clinical-stage biotechnology company, which focuses on developing and commercializing novel therapies in the emerging fields of cell therapy and regenerative medicine. Its product candidates include AST-OPC1, trial for spinal cord injuries; AST-VAC1, a patient specific cancer immunotherapy focused on acute myeloid leukemia; and AST-VAC2, a non-patient-specific cancer immunotherapy for non-small cell lung cancer. The company was founded on September 24, 2012 and is headquartered in Fremont, CA.

FDM Group (Holdings) Plc Management Consulting | London, United Kingdom

FDM Group (Holdings) Plc engages in the provision of information technology services. It focuses on development, testingm information technology service management, project management office, data services, business analysis, business intelligence, and cyber security. It operates through the following geographical segments: United Kingdom and Ireland; North America; Rest of Europe, Middle East, and Africa; and Asia Pacific. The company was founded by Roderick Neil Flavell on November 17, 2009 and is headquartered in London, the United Kingdom.

Physiomics Plc Engineering, Construction & Architecture | Oxford, United Kingdom

Physiomics Plc engages in the provision of outsourced systems and computational biology services to pharmaceutical companies. Its services include target validation, mechanism of action studies, lead selection, clinical PK or PD, EasyAP or cardiac toxicity service, virtual tumour preclinical, and virtual tumour clinical. The company was founded by David A. Fell and Peter Hoskins in May 2001 and is headquartered in Oxford, the United Kingdom.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Cancer Research UK. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Cancer Research UK's profile does not indicate a business or promotional relationship of any kind between RelSci and Cancer Research UK.